AN ANTIBODY FROM A PATIENT WITH RANITIDINE-INDUCED THROMBOCYTOPENIA RECOGNIZES A SITE ON GLYCOPROTEIN-IX THAT IS A FAVORED TARGET FOR DRUG-INDUCED ANTIBODIES
G. Gentilini et al., AN ANTIBODY FROM A PATIENT WITH RANITIDINE-INDUCED THROMBOCYTOPENIA RECOGNIZES A SITE ON GLYCOPROTEIN-IX THAT IS A FAVORED TARGET FOR DRUG-INDUCED ANTIBODIES, Blood, 92(7), 1998, pp. 2359-2365
Although thrombocytopenia associated with the use of histamine H-2 rec
eptor (H2R) antagonists has been described, a drug-dependent, platelet
-reactive antibody has not previously been identified in such cases. W
e studied serum from a patient who developed acute, severe thrombocyto
penia after exposure to the H-2 receptor antagonist, ranitidine, and i
dentified an antibody that reacted with normal platelets in the presen
ce of this drug at pharmacologic concentrations. In Row cytometric and
immunoprecipitation studies, the antibody was shown to be specific fo
r the glycoprotein Ib/IX complex (GPIb/IX), From the pattern of monocl
onal antibody (MoAb) inhibition and the reactions of antibody with Chi
nese hamster ovary (CHO) cells transfected with GPIX and GPIb beta, we
found that the patient's antibody is specific for an epitope on GPIX
close to, or identical with a site recognized by the MoAb SZ1 that is
a common target for antibodies induced by quinine and quinidine, drugs
structurally unrelated to ranitidine, These findings provide evidence
that immune thrombocytopenia can be caused by sensitivity to an H-2 R
antagonist and suggest that the SZ1 binding site on GPIX may be a com
mon target for drug-induced antibodies. Further studies of the epitope
for which SZ1 is specific may provide clues to the mechanism(s) by wh
ich drugs promote tight binding of antibody to a membrane glycoprotein
and cause platelet destruction in patients with drug sensitivity, (C)
1998 by The American Society of Hematology.